Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Miramar Labs

Explore full profile

Develops medical devices for aesthetic indications

Sunnyvale, United StatesFounded 2006Biotech & Life Sciences
Valuation $100–250M Last recorded · 2014
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Miramar Labs and the history behind them.

About Miramar Labs

Miramar Labs, Inc., founded in 2006 by Nimesh Shah and Steve Kim, is a medical device company that developed the miraDry system, a non-invasive solution for treating excessive underarm sweat, or axillary hyperhidrosis. The company originated from The Foundry, a medical device incubator, and was initially known as Foundry Newco X, Inc. before a series of name changes. A significant milestone occurred in July 2017, when Sientra, Inc., a medical aesthetics company, acquired Miramar Labs for an initial $20 million in cash, with potential for an additional $14 million in milestone-based payments.

The company's core offering is the miraDry system, which utilizes proprietary microwave technology to target and eliminate sweat and odor glands in the underarm area. This procedure, which also permanently reduces hair of all colors, received its first FDA clearance in 2011. The technology works by delivering precisely controlled electromagnetic energy that heats and destroys the glands, a process known as thermolysis, while a cooling system protects the skin's surface. The results are typically immediate and lasting, as the destroyed glands do not regenerate. The business model centers on selling the miraDry capital equipment to dermatology and plastic surgery practices and then supplying single-use applicators for each procedure, creating a recurring revenue stream. The treatment is sold through dermatologists, plastic surgeons, and aesthetic specialists directly to consumers seeking a permanent solution for underarm sweat and odor.

Miramar Labs addresses a substantial market of individuals bothered by excessive sweating. The miraDry procedure is positioned as a long-term alternative to treatments like Botox, which require repeated sessions. The treatment is performed in a clinician's office, typically taking about an hour after the administration of local anesthesia. While most patients achieve desired results with one or two treatments, a third may sometimes be necessary. The company has established a global presence, with the miraDry system available in over 50 countries.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2006
Headquarters
Sunnyvale, United States
Employees
71
Open positions
None listed
Dealroom signal
65.6/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2c

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jun 2017 $34M — Sientra —
IPO✓Exit May 2017 $9M — Undisclosed —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Miramar Labs website traffic

Latest recorded traffic for Miramar Labs is 28K monthly website visits, up 86.7% over the last three months. Miramar Labs's team declined 11.3% over the past year.

Latest monthly visits28K 3-month web change+86.7% 1-year team growth-11.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Split Rock Partners
  • Morgenthaler Ventures

Series B and later4 investors entered at this stage

  • Cross Creek Advisors
  • Domain Associates
  • Aisling Capital
  • RMI Partners

Other known investors2 additional known investors

  • Sientra
  • 1315 Capital
Team profiled 25 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
10 countries with
team presence
🇺🇸 United States78.3%
🇧🇪 Belgium3.3%
🇰🇷 South Korea3.3%
🇮🇳 India1.7%
🇦🇪 United Arab Emirates1.7%
Top 5 of 10 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Miramar Labs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Miramar Labs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.